
The glaring health equity gap in Democrats’ drug pricing plan
As Democrats close in a major Medicare prescription drug overhaul, they’re ignoring a glaring health equity issue.
Read The StoryTracking how politics and policy influence health care and medicine. To get the latest delivered to your inbox, sign up for our free D.C. Diagnosis newsletter. And subscribe to STAT+ for inside intelligence on the intersection of Capitol Hill and the life sciences.
As Democrats close in a major Medicare prescription drug overhaul, they’re ignoring a glaring health equity issue.
Read The Story